Expression of peripheral CD100 and its regulation to T lymphocytes function in patients with hepatocellular carcinoma

Huijuan FAN; Chun SONG

doi:10.3969/j.issn.1001-5256.2023.01.019

Volume 39 Issue 1

Jan. 2023

Turn off MathJax

Article Contents

Article Navigation > Journal of Clinical Hepatology > 2023 > 39(1): 128-136

PDF( 3538 KB)

Expression of peripheral CD100 and its regulation to T lymphocytes function in patients with hepatocellular carcinoma

DOI: 10.3969/j.issn.1001-5256.2023.01.019

Huijuan FAN,
Chun SONG^{,
,}

Department of Gastroenterology, The Second Affiliated Hospital to Air force Military Medical University, Xi'an 710038, China

More Information

Corresponding author: SONG Chun, 7902818098@qq.com (ORCID: 0000-0001-7896-1571)
Received Date: 2022-06-19
Accepted Date: 2022-07-22
Published Date: 2023-01-20

Abstract

Abstract

Objective To investigate the changes of peripheral CD100 in patients with hepatocellular carcinoma (HCC), and to assess the regulatory function of CD100 to T lymphocytes in HCC patients. Methods A prospective study was conducted. Fifty-seven HCC patients and twenty-two controls who were hospitalized in our hospital between April 2020 and July 2021 were enrolled. Anti-coagulant peripheral blood was collected. Plasma and peripheral blood mononuclear cells (PBMC) were isolated. Plasma soluble CD100 (sCD100) level was measured by enzyme-linked immunosorbent assay. Membrane-bound CD100 (mCD100) expression on CD4⁺ and CD8⁺ T lymphocytes was measured by flow cytometry. PBMC from HCC patients were stimulated with recombinant human CD100. Cellular proliferation was measured by cell counting kit-8. Different types of T helper cells (Th cells) and cytotoxic T cells (Tc cells) were assessed by flow cytometry. Perforin and granzyme B secretion by alpha fetoprotein (AFP) specific CD8⁺ T lymphocytes was assessed by enzyme-linked immunospot assay. CD8⁺ T lymphocytes were purified from HCC patients, and were stimulated with recombinant human CD100. Stimulated CD8⁺ T lymphocytes were co-cultured with HepG2 cells. AFP specific CD8⁺ T lymphocytes-induced HepG2 cell death was investigated. Student's t test or paired t test was used for comparison of normally distributed continuous data between two groups. Mann-Whitney U test was used for comparison of abnormally distributed continuous data between two groups. Chi square test was used for comparison of categorial data between two groups. Results Plasma sCD100 level was lower in HCC group when compared with control group ((2.73±0.58)ng/mL vs(3.33±0.84)ng/mL, t=3.584, P < 0.001). HCC group had higher percentage of mCD100⁺ cells (55.57%±11.33% vs 43.67%±6.40%, t=4.636, P < 0.001) and elevated mCD100 mean fluorescent intensity (MFI) (294.80±74.01 vs 255.00±74.01, t=2.126, P=0.037) within CD4⁺ T lymphocytes when compared with control group. Similarly, HCC group also had higher percentage of mCD100+ cells (48.65%±7.71% vs 41.74%±4.77%, t=3.914, P < 0.001) and elevated mCD100 MFI (289.20±89.30 vs 246.10±60.73, t=2.082, P=0.041) within CD8⁺ T lymphocytes when compared with control group. There were no significant differences of either cellular proliferation or T lymphocytes percentage between PBMC with and without recombinant human CD100 stimulation in HCC patients (all P > 0.05). The percentages of CD4⁺IFNγ⁺Th1 cells, CD4⁺IL-17A⁺Th17 cells, CD4⁺IL-22⁺Th22 cells, and CD8⁺IFNγ⁺Tc1 cells were notably increased in response to CD100 stimulation when compared with no CD100 stimulation (t=2.608、5.663、4.113、4605, all P < 0.05). There were no remarkably differences of either CD8⁺IL-17A⁺Tc17 or CD8⁺IL-22⁺Tc22 cell frequency between PBMCs with and without recombinant human CD100 stimulation in HCC patients (all P > 0.05). Perforin and granzyme B secretion by AFP specific CD8⁺ T lymphocytes were significantly elevated in response to CD100 stimulation when compared with no CD100 stimulation in HLA-A02 restricted HCC patients (P < 0.05). AFP specific CD8⁺ T lymphocytes-induced HepG2 cell death was also increased in response to CD100 stimulation (t=6.794、2.308, both P < 0.05). Conclusion There was an imbalance between sCD100 and mCD100 on T lymphocytes in HCC patients. Reduced sCD100 level might be insufficient for maintenance of T lymphocytes activity, leading to the immunotolerance in HCC.
- Liver Neoplasms,
- CD100,
- T-Lymphocytes

FullText(HTML)

References(21)

References

[1]	Chinese Society of Hepatology, Chinese Medical Association. Consensus on the secondary prevention for primary liver cancer (2021 edition)[J]. J Clin Hepatol, 2021, 37(3): 532-542. DOI: 10.3969/j.issn.1001-5256.2021.03.008. 中华医学会肝病学分会. 原发性肝癌二级预防共识(2021年版)[J]. 临床肝胆病杂志, 2021, 37(3): 532-542. DOI: 10.3969/j.issn.1001-5256.2021.03.008.
[2]	KALATHIL SG, THANAVALA Y. Natural killer cells and T cells in hepatocellular carcinoma and viral hepatitis: current status and perspectives for future immunotherapeutic approaches[J]. Cells, 2021, 10(6): 1332. DOI: 10.3390/cells10061332.
[3]	YANG S, WANG L, PAN W, et al. MMP2/MMP9-mediated CD100 shedding is crucial for inducing intrahepatic anti-HBV CD8 T cell responses and HBV clearance[J]. J Hepatol, 2019, 71(4): 685-698. DOI: 10.1016/j.jhep.2019.05.013.
[4]	LI BJ, HE Y, ZHANG Y, et al. Interferon-α-induced CD100 on naïve CD8⁺ T cells enhances antiviral responses to hepatitis C infection through CD72 signal transduction[J]. J Int Med Res, 2017, 45(1): 89-100. DOI: 10.1177/0300060516676136.
[5]	ZHANG DN, LIU Y, LI X, et al. Imbalance between soluble and membrane-bound CD100 regulates monocytes activity in hepatitis B virus-associated acute-on-chronic liver failure[J]. Viral Immunol, 2021, 34(4): 273-283. DOI: 10.1089/vim.2020.0311.
[6]	WANG HM, ZHANG XH, YE LQ, et al. Insufficient CD100 shedding contributes to suppression of CD8⁺ T-cell activity in non-small cell lung cancer[J]. Immunology, 2020, 160(2): 209-219. DOI: 10.1111/imm.13189.
[7]	Bureau of Medical Administration, National Health Commission of the People's Republic of China. Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition)[J]. J Clin Hepatol, 2020, 36(2): 277-292. DOI: 10.3969/j.issn.1001-5256.2020.02.007. 中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗规范(2019年版)[J]. 临床肝胆病杂志, 2020, 36(2): 277-292. DOI: 10.3969/j.issn.1001-5256.2020.02.007.
[8]	YANG L, SHAO X, JIA S, et al. Interleukin-35 dampens CD8⁺ T cells activity in patients with non-viral hepatitis-related hepatocellular carcinoma[J]. Front Immunol, 2019, 10: 1032. DOI: 10.3389/fimmu.2019.01032.
[9]	LIU H, YANG Y, XIAO J, et al. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients[J]. Microvasc Res, 2014, 93: 1-8. DOI: 10.1016/j.mvr.2014.02.007.
[10]	CHEN Y, ZHANG L, LV R, et al. Overexpression of Semaphorin4D indicates poor prognosis and prompts monocyte differentiation toward M2 macrophages in epithelial ovarian cancer[J]. Asian Pac J Cancer Prev, 2013, 14(10): 5883-5890. DOI: 10.7314/apjcp.2013.14.10.5883.
[11]	LU JJ, SU YW, WANG CJ, et al. Semaphorin 4D promotes the proliferation and metastasis of bladder cancer by activating the PI3K/AKT pathway[J]. Tumori, 2019, 105(3): 231-242. DOI: 10.1177/0300891618811280.
[12]	CHEN WG, SUN J, SHEN WW, et al. Sema4D expression and secretion are increased by HIF-1α and inhibit osteogenesis in bone metastases of lung cancer[J]. Clin Exp Metastasis, 2019, 36(1): 39-56. DOI: 10.1007/s10585-018-9951-5.
[13]	LIU B, MA Y, ZHANG Y, et al. CD8low CD100- T cells identify a novel CD8 T cell subset associated with viral control during human hantaan virus infection[J]. J Virol, 2015, 89(23): 11834-11844. DOI: 10.1128/JVI.01610-15.
[14]	YOSHIDA Y, OGATA A, KANG S, et al. Semaphorin 4D contributes to rheumatoid arthritis by inducing inflammatory cytokine production: pathogenic and therapeutic implications[J]. Arthritis Rheumatol, 2015, 67(6): 1481-1490. DOI: 10.1002/art.39086.
[15]	GANG HS, PENG DF, HU YJ, et al. Regulation of CD100 on T lymphocytes function in septic cardiomyopathy patients[J]. Clin J Emerg Med, 2020, 29(11): 1432-1438. DOI: 10.3760/cma.j.issn.1671-0282.2020.11.009. 冮洪生, 彭定凤, 胡勇钧, 等. CD100对脓毒性心肌病患者T淋巴细胞功能的调控作用[J]. 中华急诊医学杂志, 2020, 29(11): 1432-1438. DOI: 10.3760/cma.j.issn.1671-0282.2020.11.009.
[16]	FRANCO F, JACCARD A, ROMERO P, et al. Metabolic and epigenetic regulation of T-cell exhaustion[J]. Nat Metab, 2020, 2(10): 1001-1012. DOI: 10.1038/s42255-020-00280-9.
[17]	DONISI C, PUZZONI M, ZIRANU P, et al. Immune checkpoint inhibitors in the treatment of HCC[J]. Front Oncol, 2020, 10: 601240. DOI: 10.3389/fonc.2020.601240.
[18]	LI M, O'SULLIVAN KM, JONES LK, et al. CD100 enhances dendritic cell and CD4⁺ cell activation leading to pathogenetic humoral responses and immune complex glomerulonephritis[J]. J Immunol, 2006, 177(5): 3406-3412. DOI: 10.4049/jimmunol.177.5.3406.
[19]	ST PAUL M, OHASHI PS. The roles of CD8⁺ T cell subsets in antitumor immunity[J]. Trends Cell Biol, 2020, 30(9): 695-704. DOI: 10.1016/j.tcb.2020.06.003.
[20]	IWAHORI K. Cytotoxic CD8⁺ lymphocytes in the tumor microenvironment[J]. Adv Exp Med Biol, 2020, 1224: 53-62. DOI: 10.1007/978-3-030-35723-8_4.
[21]	LI Y, QIN L, BAI Q, et al. CD100 modulates cytotoxicity of CD8⁺ T cells in patients with acute myocardial infarction[J]. BMC Immunol, 2021, 22(1): 13. DOI: 10.1186/s12865-021-00406-y.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(3) / Tables(5)

Get Citation

PDF

XML

Article Metrics

Article views (1718) PDF downloads(83)

Expression of peripheral CD100 and its regulation to T lymphocytes function in patients with hepatocellular carcinoma

DOI: 10.3969/j.issn.1001-5256.2023.01.019

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Expression of peripheral CD100 and its regulation to T lymphocytes function in patients with hepatocellular carcinoma

DOI: 10.3969/j.issn.1001-5256.2023.01.019

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content